Samsung Biologics to acquire PolyPeptide Group for KRW2.706T
Samsung Biologics plans to acquire 100% of PolyPeptide Group for KRW2.706T.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Samsung Biologics plans to acquire 100% of PolyPeptide Group for KRW2.706T.